Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $196K | +5K | +5.87% | $39.15 | 90.1K | Mar 16, 2023 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$1M | -5K | -5.55% | $199.90 | 85.1K | Mar 16, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -5K | -28.66% | $0.00 | 12.4K | Mar 16, 2023 | Common Stock | 5K | $39.15 | Direct | F3 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19. |